Danaher Corp logo

Danaher Corp DHR

Market Closed
14 Jun, 20:00
NYSE NYSE
$
254. 85
-0.16
-0.06%
After Hours
$
254. 85
-0 -0%
191.36B Market Cap
28.65 P/E Ratio
1.08% Div Yield
3,021,000 Volume
7.58 Eps
$ 255.01
Previous Close
Day Range
252.95 254.87
Year Range
182.09 269.11

DHR Chart

Danaher Corp Profile

Diagnostics & Research Industry
Healthcare Sector
Mr. Steven M. Rales CEO
NYSE Exchange
US2358511028 ISIN
US Country
61,000 Employees
- Last Dividend
23 Jan 1995 Last Split
5 Jan 1979 IPO Date

Overview

Danaher Corporation is a global powerhouse in the design, manufacturing, and marketing of a vast array of professional, medical, industrial, and commercial products and services. With its inception in 1969 and a significant rebranding in 1984, where it transitioned from Diversified Mortgage Investors, Inc. to Danaher Corporation, the company has established a formidable presence in various sectors. Headquartered in Washington, D.C., Danaher stands out through its commitment to innovation, excellence, and enhancing the quality of life worldwide.

Products and Services

  • Biotechnology: Danaher's biotechnology segment is a provider of bioprocess technologies, consumables, and services enhancing the development and manufacture of therapeutics. This includes cell line and cell culture media development, chromatography resins, filtration technologies, aseptic fill-finish solutions, single-use hardware, and comprehensive services aimed at setting up full manufacturing suites.
  • Life Sciences: This segment delivers a wide range of products including mass spectrometers, flow cytometry, genomics solutions, lab automation instruments, centrifugation, liquid handling automation instruments, antibodies and reagents, particle counting and characterization tools, microscopes, and protein consumables. Among the notable brands under the Life Sciences segment are ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX, each providing specialized products for genomic medicines and industrial filtration.
  • Diagnostics: Danaher’s diagnostics sector offers a comprehensive range of chemistry, immunoassay, microbiology, automation systems, molecular diagnostics, acute care, and pathology diagnostics products. Aimed at hospitals, physicians' offices, reference laboratories, and other critical care settings, this segment ensures the delivery of clinical instruments, reagents, consumables, software, and dedicated services to support critical diagnostics.

Contact Information

Address: 2200 Pennsylvania Avenue, North West, Washington, DC, United States, 20037-1701
Phone: 202 828 0850